AnandRathi

Remus Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
910.15
+19.65 (+2.21%)

Remus Pharmaceuticals Ltd (Remus Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,073 crore.

Remus Pharmaceuticals Ltd Overview

Market cap₹1,073 Crs
Volume5,200
Prev. Close₹890.50
Year range₹580.00 - ₹987.50
Total Value₹47,32,780.00
ISININE0O5T01011

Remus Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)10.19%
P/E Ratio (TTM)43.40
P/B Ratio3.29
Debt to Equity0.02
ROE7.59%
EPS (TTM)20.97
Dividend Yield0.05%
Book Value276.40
Profit Margin0.00%
Operating Margin0.00%

Remus Pharmaceuticals Ltd Historical Performance

1 Month Return26.23%
6 Month Return36.05%
3 Year Return61.55%
3 Month Return27.73%
1 Year Return-1.99%
5 Year Return-

Remus Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research